Results 281 to 290 of about 203,049 (341)

Initial clinical experience with dapagliflozin in addition to optimized medical therapy in paediatric heart failure patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Dapagliflozin, a sodium‐glucose cotransporter 2 (SGLT2) inhibitor, has shown clinical benefits in adults with heart failure (HF), improving cardiac function, reducing HF‐related hospitalizations and enhancing survival rates. While extensively studied in adult HF, data on its efficacy and safety in paediatric HF patients remain limited. We
Lisa‐Maria Rosenthal   +5 more
wiley   +1 more source

Outcome after left ventricular assist device exchange. [PDF]

open access: yesEur J Cardiothorac Surg
Niamat J   +5 more
europepmc   +1 more source

Prognostic impact of peak oxygen consumption in heart failure: A systematic review and meta‐analysis

open access: yesESC Heart Failure, EarlyView.
Based on 64 studies, each 1 mL/kg/min increase in VO2peak significantly reduced all‐cause mortality (HR: 0.86, 95% CI 0.82–0.90) and combined outcomes of ventricular assist device, transplant and all‐cause mortality (HR: 0.84, 95% CI 0.79–0.89) in patients with heart failure, though no significant association was observed with cardiovascular mortality (
Konstantinos Prokopidis   +6 more
wiley   +1 more source

Exploratory analysis of long-term suppressive therapy with dalbavancin in ventricular assist device infections caused by Staphylococcus aureus. [PDF]

open access: yesSci Rep
Morath B   +12 more
europepmc   +1 more source

Clinical characteristics and outcomes of adults with acute heart failure in a South African teaching hospital

open access: yesESC Heart Failure, EarlyView.
In this study of 406 adults admitted with acute heart failure, the overall in‐hospital mortality rate was 3.4%. Independent predictors of in‐hospital mortality included elevated neutrophil‐lymphocyte ratio, C‐reactive protein, and potassium levels, along with moderate or severe aortic regurgitation and lower diastolic blood pressure.
Umar G. Adamu   +2 more
wiley   +1 more source

Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology

open access: yesEuropean Journal of Heart Failure, EarlyView.
For most patients with chronic, progressive illnesses, maintaining good quality of life (QoL), with preserved functional capacity, is just as crucial as prolonging survival. Patients with heart failure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a ...
Maurizio Volterrani   +21 more
wiley   +1 more source

Myocardial functional recovery following durable ventricular assist device in children. [PDF]

open access: yesJHLT Open
Langanecha B   +9 more
europepmc   +1 more source

The prognostic value of the Dandel's index in patients undergoing tricuspid transcatheter edge‐to‐edge repair

open access: yesEuropean Journal of Heart Failure, EarlyView.
Load adaptation indices and concepts. An adapted RV in response to overload increases wall thickness to normalize wall stress and preserve function and morphology. If hemodynamic overload is sustained, it can progress to a maladaptive state and lead eventually to heart failure. CI, cardiac index; Ees, ventricular elastance; Ea, arterial elastance; MPAP,
Mohammad Kassar   +39 more
wiley   +1 more source

Home - About - Disclaimer - Privacy